ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Dallas, TX, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Dallas, Texas, United States and 8 other locations

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Not yet enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Dallas, Texas, United States and 18 other locations

COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention...

Active, not recruiting
Diabetes Mellitus, Type 2
Cardiovascular Diseases
Other: Intense Education Intervention
Duke University
Duke University

Dallas, Texas, United States and 43 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Enrolling
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Irving, Texas, United States and 18 other locations

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Fort Worth, Texas, United States and 56 other locations

Adolescents with Type 1 Diabetes (age 13-18 years, T1D duration \>6 months managed on insulin) and poor glycemic control will wear a blinded...

Enrolling
Diabetes Mellitus, Type 1
Noncompliance, Patient
Other: Continuous Glucose Monitoring
Other: Secure texting
The University of Texas System (UT)
The University of Texas System (UT)

Dallas, Texas, United States

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Dallas, Texas, United States of America and 24 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Dallas, Texas, United States and 35 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Dallas, Texas, United States of America and 89 other locations

New

randomized control study that will evaluate the safety and effectiveness of the embecta Automated Insulin Delivery System in adults with Type 2 diabetes...

Begins enrollment in 1 month
Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes
Other: Standard of Care (SC)
Device: An AID System.
Embecta Corp.

Dallas, Texas, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems